Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.
Onko sinulla jo Inderes-tili?
Follow this company like 10711 other investors.
Analyytikko
Remedy is now building the next growth leap of its strategy with the 5 major game projects under development. This will be reflected in rising costs between 2022 and 2023, but enable significant earnings growth particularly in 2025-2026, driven by increasing royalty income.
Remedy Entertainment Plc | Stock Exchange Release 9.30 am (EEST) May 31, 2022
Remedy Entertainment Plc applies for listing of option rights 2019
Remedy Entertainment Plc (the "Company") will apply for the listing of its 2019 option rights on the Nasdaq Helsinki Ltd First North Growth marketplace as of June 1, 2022.
Redeye has done some adjustments after the Q1 result. Remedy has five ongoing projects which means one of the biggest challenges going forward is to find the best possible personnel to recruit.
Remedy's Q1 result was stronger than we had expected, but the main thing was that the 5 major game projects under development are progressing as planned.
Redeye comments on Remedy’s Q1 business review. Revenue was EUR 1.3 million above our estimate, EUR 12.7 million versus EUR 11.4 million. The cost base was roughly in line, which resulted in an EBIT somewhat above our estimate.
Remedy Entertainment Plc | Stock Exchange Release 10:00 am (EEST) May 13, 2022BUSINESS REVIEW January 1 - March 31, 2022 (unaudited)
Steady progress across the game roadmap
Record high cash flow from operations
Remedy Entertainment Plc | Stock Exchange Release 3.20 p.m. (EEST) 3 May 2022
Remedy Entertainment Plc's listing application has been approved; trading in the shares on the official list of Nasdaq Helsinki Ltd will commence on 4 May 2022
Remedy Entertainment Plc | Stock Exchange Release 3:45 p.m. (EEST) 27 April 2022
The Finnish Financial Supervisory Authority has approved Remedy Entertainment Plc's Finnish language prospectus
The Finnish Financial Supervisory Authority has today approved Remedy Entertainment Plc's ("Remedy" or the "Company") Finnish language prospectus (the "Prospectus"). The Prospectus is published in connection with the Company's transfer from the Nasdaq First North Growth Market Finland marketplace to the official list of Nasdaq Helsinki Ltd ("Nasdaq Helsinki").
Remedy Entertainment Plc | Stock Exchange Release 2.30 p.m. (EEST) 27 April 2022
Remedy Entertainment Plc has applied for its shares to be listed on the official list of Nasdaq Helsinki Ltd
Remedy Entertainment Plc | Company Announcement 10.15 a.m. (EEST) 26 April 2022
Remedy Entertainment Plc - Correction: Adoption of IFRS and unaudited IFRS comparison figures